1) Premium content: UPC’s Roche-Menarini preliminary injunction clarifies relationship between independent product and manufacturing method claims

An independent method claim cannot, without more, result in further requirements for the infringement of an independent product claim.

2) Free content: 10x Genomics, Moderna, Novo Nordisk among newly confirmed speakers for Patent Litigation Europe event (pharma & tech) next month

Eric Whitaker, Chief Legal Officer at 10x Genomics, Karen Guo, Senior Director of Patents & IP at Novo Nordisk, and Katherine Hinterberg, Senior Director of Patent Litigation at Moderna, will speak at Kisaco Research’s annual Pharma and Biotech Patent Litigation Europe in Amsterdam.

3) Premium content: Optical fibre cable maker’s invalidation claims were “valiant” but “fell flat”, EWHC rules in Fujikura v. Sterlite patent infringement decision

The High Court of Justice for England & Wales has ruled that a patent asserted by Japanese electrical equipment manufacturer Fujikura is valid and has been infringed by a range of Indian rival Sterlite’s fiber optic cables.

4) Partly free content: U.S. and Asian companies bring vast majority of major Unified Patent Court infringement cases, reflective of EU weakness in innovation

About one third of the last 100 UPC infringement actions were brought by companies headquartered in a contracting member state, but most of them are small. In other news today, J.P. Morgan's CEO has said Europe has driven out business, driven out investment, driven out innovation.

5) Free guest article: Cellular SEP aggregate royalty rate for carrier network equipment

This article was authored by Professor John Gong of the Department of Economics of the University of International Business and Economics (Beijing). Guest articles reflect the opinions of their authors, not those of ip fray.

6) LinkedIn: Paramount makes hostile bid for Warner Bros. Discovery

Relevant with a view to the streaming patent licensing market.